Healthcare Business

Study Shows How Pomegranates May Help Keep Us Younger

Swiss researchers have established that tannins found in pomegranates are converted in the digestive system into a compound that appears to slow down mitochondrial aging -- a natural process that ...
Read Full Story »

Why This FDA Approval for Pneumonia Treatment Is So Huge

This story has been updated for share price impact. Melinta Therapeutics, Inc. (NASDAQ: MLNT) shares nearly doubled early on Wednesday after the firm announced that the U.S. Food and Drug ...
Read Full Story »

One Firm Sees Up to 45% Upside in Top Companies in Life Sciences Tools

Investing in the life sciences tool sector can be tricky, but according to the financial services firm Janney, the investing gain will be a result of finding the right secular ...
Read Full Story »

Two Very Speculative Biotechs With Promising Alzheimer’s Treatment Hopefuls

The biotechnology sector is generally considered the most volatile and riskiest sector within all of healthcare. Some companies have created massive wealth in this sector. And some companies have produced ...
Read Full Story »

Tuesday’s Top BioPharma Movers Deviating from the Market

Tuesday was a breakout day for a few biotech companies, and that was the case even before news broke that the U.S. and China would be meeting at the G20 ...
Read Full Story »

How PhaseBio Pharma Could Change the Game in Antiplatelet Therapy

Shares of PhaseBio Pharmaceuticals, Inc. (NASDAQ: PHAS) jumped on Tuesday after the firm announced preliminary results from its mid-stage trial for dual antiplatelet therapy of the blood thinner ticagrelor and ...
Read Full Story »

How Aclaris Is On Track to Treat Baldness

Baldness and hair thinning is something that many men and women fear as they age, and understandably so. But Aclaris Therapeutics, Inc. (NASDAQ: ACRS) may have found an answer to ...
Read Full Story »

Can This Pill Stave Off Alzheimer’s While Lowering Blood Pressure?

A blood pressure medication widely used in Europe and Japan might have potential to slow down the progress of Alzheimer’s disease, according to a new study appearing in Hypertension, a ...
Read Full Story »

How Much Is Pfizer Overpaying For Array Bio?

Array BioPharma Inc. (NASDAQ: ARRY) shares shot up on Monday after the firm announced that it would be acquired by Pfizer Inc. (NYSE: PFE) in an all cash transaction. The ...
Read Full Story »

This Form of Cancer Will Kill More People Than the Most Common Cancer in 2019

Annual deaths from cancer have dropped 27% in the last 25 years, according to the American Cancer Society (ACS). However, the death rates for some have barely dropped, and some ...
Read Full Story »

High Hopes and Expectations for Merck’s First Investor Day in Years

Merck & Co. Inc. (NYSE: MRK) may still be up in 2019, and it may be better off for now than rival Pfizer, but the reality is that Merck shares ...
Read Full Story »

Why ArQule’s Early-Stage Hematology Study Could Be Transformational

ArQule Inc. (NASDAQ: ARQL) shares jumped early on Friday after the firm announced preliminary results from an early-stage study in patients with relapsed or refractory hematologic malignancies at the 2019 ...
Read Full Story »

Investors Need Some Breathing Room From Savara’s Lung Treatment

Savara Inc. (NASDAQ: SVRA) shares were absolutely crushed on Thursday after the company released its late-stage results for its treatment of autoimmune pulmonary alveolar proteinosis (aPAP). Unfortunately, the study did ...
Read Full Story »

Multimillion-Dollar Medical Claims Continue to Skyrocket

Whether you were in favor of or against the Affordable Care Act, aka Obamacare, it is likely of little surprise that the cost of health care has continued to rise. ...
Read Full Story »

Big Biotechs Have Short Sellers on the Run

The short interest data are out for the most recent settlement date, May 31. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »